Aprea Therapeutics Inc (APRE) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Historical revenue and profitability trends for Aprea Therapeutics Inc
The chart above illustrates Aprea Therapeutics Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Aprea Therapeutics Inc's business.
How efficiently Aprea Therapeutics Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Aprea Therapeutics Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Aprea Therapeutics Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.3333 based on 3 analysts.
Based on our comprehensive analysis, Aprea Therapeutics Inc (APRE) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Aprea Therapeutics Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Aprea Therapeutics Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: APRE Valuation, APRE Dividend, APRE Financial Health
Compare: APRE vs AAPL, APRE vs MSFT, APRE vs GOOGL